RU2018126749A3 - - Google Patents

Download PDF

Info

Publication number
RU2018126749A3
RU2018126749A3 RU2018126749A RU2018126749A RU2018126749A3 RU 2018126749 A3 RU2018126749 A3 RU 2018126749A3 RU 2018126749 A RU2018126749 A RU 2018126749A RU 2018126749 A RU2018126749 A RU 2018126749A RU 2018126749 A3 RU2018126749 A3 RU 2018126749A3
Authority
RU
Russia
Application number
RU2018126749A
Other languages
Russian (ru)
Other versions
RU2809222C2 (ru
RU2018126749A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49000959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2018126749(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2018126749A publication Critical patent/RU2018126749A/ru
Publication of RU2018126749A3 publication Critical patent/RU2018126749A3/ru
Application granted granted Critical
Publication of RU2809222C2 publication Critical patent/RU2809222C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018126749A 2012-08-24 2018-07-20 Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия RU2809222C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261692911P 2012-08-24 2012-08-24
US61/692,911 2012-08-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2015110240A Division RU2667643C2 (ru) 2012-08-24 2013-08-22 Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия

Publications (3)

Publication Number Publication Date
RU2018126749A RU2018126749A (ru) 2019-03-12
RU2018126749A3 true RU2018126749A3 (enExample) 2021-12-28
RU2809222C2 RU2809222C2 (ru) 2023-12-07

Family

ID=

Also Published As

Publication number Publication date
PL2887961T3 (pl) 2021-11-08
IL237114A0 (en) 2015-03-31
CA2882771C (en) 2021-02-23
CL2015000426A1 (es) 2015-10-02
BR112015003067A2 (pt) 2017-07-04
IL237114B (en) 2020-10-29
US20150190376A1 (en) 2015-07-09
WO2014029848A1 (en) 2014-02-27
US11135192B2 (en) 2021-10-05
RU2015110240A (ru) 2016-10-20
SI2887961T1 (sl) 2021-08-31
JP6482462B2 (ja) 2019-03-13
HUE054885T2 (hu) 2021-10-28
CA2882771A1 (en) 2014-02-27
KR20150046039A (ko) 2015-04-29
US20180200218A1 (en) 2018-07-19
ZA201500262B (en) 2016-09-28
MX378867B (es) 2025-03-11
JP2022020624A (ja) 2022-02-01
CN104602711A (zh) 2015-05-06
PH12015500375A1 (en) 2015-04-20
AU2013304949A1 (en) 2015-02-05
US20170049738A1 (en) 2017-02-23
JP2019069954A (ja) 2019-05-09
MX2015002432A (es) 2015-06-22
HK1205930A1 (en) 2015-12-31
US9517226B2 (en) 2016-12-13
KR20200111822A (ko) 2020-09-29
US9937143B2 (en) 2018-04-10
PT2887961T (pt) 2021-07-28
SG11201500256UA (en) 2015-04-29
RU2018126749A (ru) 2019-03-12
EP2887961A1 (en) 2015-07-01
EP3943084A1 (en) 2022-01-26
RU2667643C2 (ru) 2018-09-21
TWI634887B (zh) 2018-09-11
KR102159601B1 (ko) 2020-09-28
MA37850A1 (fr) 2018-07-31
NZ704604A (en) 2018-06-29
JP7407508B2 (ja) 2024-01-04
JP2023159114A (ja) 2023-10-31
JP2015526458A (ja) 2015-09-10
CN108685889A (zh) 2018-10-23
AU2013304949C1 (en) 2020-12-24
EP2887961B1 (en) 2021-04-28
TW201414471A (zh) 2014-04-16
TN2015000028A1 (en) 2016-06-29
ES2879550T3 (es) 2021-11-22
DK2887961T3 (da) 2021-07-19
AU2013304949B2 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
BR112014018444A2 (enExample)
BR112014017625A2 (enExample)
BR112014017659A2 (enExample)
BR112014017607A2 (enExample)
BR112014017646A2 (enExample)
BR112014018631A2 (enExample)
BR112014018026A2 (enExample)
AR092201A1 (enExample)
BR112013027865A2 (enExample)
BR112014022572A2 (enExample)
BR112014017644A2 (enExample)
BR112014020185A2 (enExample)
BR112014017634A2 (enExample)
BR112014019640A2 (enExample)
BR112014017647A2 (enExample)
BR112014017627A2 (enExample)
BR112014017623A2 (enExample)
BR112014017652A2 (enExample)
BR112014017630A2 (enExample)
BR112014017621A2 (enExample)
BR112014017631A2 (enExample)
BR112014017671A2 (enExample)
BR112014017589A2 (enExample)
BR112015012654A2 (enExample)
BR112014017600A2 (enExample)